| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 17.759 | 74.551 | 3.269 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 17.759 | 74.884 | 3.269 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 23.852 | 66.772 | 9.224 | 448 | 0 | 1.552 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -6.093 | 8.112 | -5.954 | -448 | 0 | -1.552 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -6.626 | 7.003 | -6.026 | -448 | 0 | -1.552 | 0 | 0 | 0 | 0 |
| Employees | 2 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Altamedica Publishing Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 784 | 541 | 532 | 522 | 512 | 502 | 491 | 493 | 491 | 0 |
| Current Assets | 2.963 | 9.765 | 2.069 | 114 | 111 | 214 | 209 | 210 | 209 | 74 |
| Inventories | 170 | 451 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 5.785 | 554 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 2.793 | 3.528 | 1.515 | 114 | 111 | 214 | 209 | 210 | 209 | 74 |
| Shareholders Funds | -6.581 | 534 | -5.501 | -5.849 | -5.735 | -7.178 | -7.019 | -7.041 | -7.019 | -6.980 |
| Social Capital | 45 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 10.327 | 9.772 | 8.102 | 6.484 | 6.359 | 7.895 | 7.720 | 7.743 | 7.720 | 7.054 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5812 - 5812" | |||||||||
| CAEN Financial Year |
5813
|
|||||||||
Comments - Altamedica Publishing Srl